The Scientist

» drug development, immunology and microbiology

Most Recent

image: Nanobombs Terminate Foodborne Microbes

Nanobombs Terminate Foodborne Microbes

By | March 5, 2015

Researchers engineer water nanostructures to wipe out pathogens that can spoil food and pose health risks.

2 Comments

image: Tough-to-Clean Equipment a Bigger Problem

Tough-to-Clean Equipment a Bigger Problem

By | March 2, 2015

The number of deaths attributable to certain medical probes may go beyond a recent outbreak in Los Angeles.

2 Comments

image: Of Cells and Limits

Of Cells and Limits

By | March 1, 2015

Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

3 Comments

image: Fighting Allergy with Allergen

Fighting Allergy with Allergen

By | February 25, 2015

Babies who ate peanuts were less likely to develop an allergy to the food by the time they hit kindergarten, according to a new study.

4 Comments

image: Medical Equipment May Spread Superbug

Medical Equipment May Spread Superbug

By | February 20, 2015

Drug-resistant bacteria have spread in a Los Angeles hospital, perhaps from contaminated endoscopes.

1 Comment

image: Clinic Trial Problems Kept Mum

Clinic Trial Problems Kept Mum

By | February 11, 2015

Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.

0 Comments

image: Subway Microbiome

Subway Microbiome

By | February 9, 2015

Researchers document the bacterial life living among New York City’s transit stations.

0 Comments

image: Long-Lived Immunotherapy Stem Cells

Long-Lived Immunotherapy Stem Cells

By | February 4, 2015

Genetically modified T memory stem cells persist in patients for more than 10 years, and can differentiate into a variety of T cell types.

1 Comment

image: B Cell Bosses

B Cell Bosses

By | February 1, 2015

Gut bacteria in mice spur regulatory B cells to differentiate and release an anti-inflammatory cytokine.

0 Comments

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS